Tenax Therapeutics’ management will also participate in one-on-one investor meetings. To request a one-on-one meeting at the conference, please contact your Guggenheim representative. The live and ...
Tenax Therapeutics (TENX) is in a very good position as far as its drug development plan goes for its drug levosimendan. That's because it is already in the process of running the ongoing phase 3 ...
East Baltimore, Md.-based Tenax Corp. will invest $1 million into manufacturing plant updates and recycling capabilities at its Evergreen, Ala., site as part of an effort expected to create jobs while ...
CHAPEL HILL, N.C., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results